Photobiomodulation in Dry Age Related Macular Degeneration (DRUSEN)
Age-Related Macular Degeneration
About this trial
This is an interventional treatment trial for Age-Related Macular Degeneration focused on measuring Age related Macular Degeneration, Photobiomodulation
Eligibility Criteria
Inclusion Criteria: BCVA ETDRS > 40 L ETDRS at 4 meters Diagnosis of DRY AMD AREDS grade 2-3 Ability to communicate well with the investigator and able to understand and comply with the requirements of the study Exclusion Criteria: Concomitant epilepsy Neurological diseases Psychiatric pathologies Herpes virus infections Dense cataract Pregnancy Other significant ocular and/or retinal diseases
Sites / Locations
- University of ParisRecruiting
- Università degli Studi di FerraraRecruiting
- Università degli studi della Campania Luigi VanvitelliRecruiting
- Università di TorinoRecruiting
- University of AnkaraRecruiting
- Koç University HospitalRecruiting
- Earlam and ChristopherRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Treatment group
Sham group
Two cycles of treatment using continuous and pulsed yellow light followed by continuous and pulsed red light. Cycle 1 consists of 8 sessions (two sessions per week for 4 weeks) and cycle 2 consists of 6 sessions (two sessions per week for 3 weeks).
Sham treatment will occur using a sham mask, designed to release a very low level of light, in this way the patient will not be able to distinguish if he is receiving the treatment or not. Cycle 1 consists of 8 sessions (two sessions per week for 4 weeks) and cycle 2 consists of 6 sessions (two sessions per week for 3 weeks).